Form N-CSR BlackRock Enhanced Equit For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260305/AM2VU22CZZ2RLTZ222Z52ZYMIDKIZZ22X28Q
Filed on: March 5, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackRock Files to Offer ETF Share Classes on Five Active Mutual Funds
- Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline
- Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
